Blaztere 4 Mg Injection

Blaztere 4 mg is used to manage high calcium levels in the blood, known as hypercalcemia which is predominantly seen in cancer patients. Additionally, it is also used in treating multiple myeloma, paget’s disease of bones, osteoporosis, etc. It belongs to a group of medications called bisphosphonates. 

Key Features

How does Blaztere 4 mg work?

Balztere 4 mg contains zoledronic acid which acts by binding to the bone tightly and preventing the removal of osteoclasts, a type of bone cell that destroys bone tissue. This eventually prevents osteoclasts from breaking down the bone and keeps the bones strong and minimizes the risk of breaking.

Directions for use

The injection is delivered through an intravenous method. It should never be self-administered. It is generally administered within 3-4 weeks. 

Dosage

Use as and when prescribed by the healthcare provider. 

Substitutes

Zobone 4 mg

Zolasta 4 mg

Zyclastin 4 mg

Uses

Blaztere 4 mg can be used for:

• • Osteoporosis
  • Paget’s bone disease-chronic skeletal disorder
  • Hypercalcemia of malignancy 
  • Cancer related bone damage

Side effects

• Nausea
• Constipation
• Shortness of breath
• Diarrhea
• Pain at the injection site
• Redness or swelling of eyes
• Muscle or joint pain
• Loss of appetite

Interactions

• Nephrotoxic drugs

Nephrotoxic drugs like ACE inhibitors, ibuprofen, acetaminophen, etc should not be used in combination with Zolasta 4 mg as it can increase the risk of renal failure. 

• Diuretics

Loop diuretics like furosemide can increase the risk of developing critical hypoglycemia. 

• Bisphosphonates & Calcitonin

Concomitant use of bisphosphonates and Zolasta 4 mg should be avoided as it can drastically reduce the level of calcium levels in the body. 

Precautions & Warnings

• Do not use the injection if you are allergic to Zoledronic acid or any other ingredient of the injection
• Strict monitoring and specific safety precautions should be followed
• It is generally unsafe during pregnancy and breast feeding as it can cause fetal harm.
• Do not drive or operate heavy machineries until you know how the medication affects your body. 
• It is generally advised to avoid alcohol or limit during the treatment.
• It is not advised to be used in children and adolescents under 18 years of age. 

Conclusion

Blaztere 4 mg is a zoledronic acid based bisphosphonate injection used to treat osteoporosis, Paget’s disease of bone, cancer-related bone complications, and hypercalcemia of malignancy. By slowing the activity of osteoclasts, it helps reduce bone loss, strengthen bones, and lower the risk of fractures and skeletal complications. The injection is administered intravenously under medical supervision and should never be self-administered. 

FAQ’s